Strategic Advisor

Helping healthcare and pharmaceutical leaders navigate complex systems and strategic decisions.

II work at the intersection of health markets, evidence, and strategy—supporting organizations in turning complexity into clear direction and long-term value.

View selected workGet in touch

Expertise & Domains

Core Competencies

A structured framework of expertise developed across 15+ years of strategic engagement with complex organizations. Each domain represents deep, applied knowledge in solving high-stakes challenges.

01

Estratégia de Mercado & Evidências

Tradução de epidemiologia, evidência clínica e dados de mundo real em posicionamento estratégico. Apoio decisões de preço, acesso, priorização de portfólio e estratégia de mercado em ambientes regulatórios complexos.

Market Access Real-World Evidence Health Economics Portfolio Strategy
02

Uso Estratégico de Dados

Uso dados não como produto final, mas como instrumento de decisão. Estruturo informações para explicitar trade-offs, quantificar incertezas e sustentar escolhas executivas defensáveis.

Decision Support Advanced Analytics Data-Driven Strategy Performance Intelligence
03

Dinâmica dos Sistemas de Saúde

Análise de como incentivos, regulação, prestadores, pagadores e indústria interagem dentro do sistema de saúde. Identifico alavancas estruturais que influenciam adoção, reembolso e captura de valor no longo prazo.

Health Policy Reimbursement Strategy Stakeholder Alignment System-Level Analysis
04

Advisory Executivo & Posicionamento

Apoiei lideranças seniores a tomar decisões em contextos complexos. Integro inteligência competitiva, capacidades organizacionais e dinâmica de mercado para construir uma direção estratégica coerente.

Executive Counsel Strategic Positioning Competitive Landscape Long-Term Value Creation

Projects & Platforms

Selected Work

A curated selection of strategic initiatives developed across the healthcare and pharmaceutical ecosystem. These engagements address complex challenges - market access, evidence generation, health system dynamics, and strategic positioning - where rigorous analysis and clear judgment are required to guide high-stakes decisions.

Concepção da metodologia analítica para transformar dados públicos de oncologia em evidências para a tomada de decisão.

Plataforma Prisma

Cliente: Novartis Os dados públicos de saúde do Brasil possuem um enorme potencial para compreender como o cuidado ao câncer de mama é realizado em todo o sistema de saúde. No entanto, extrair insights relevantes dessas bases exige muito mais do que acesso técnico aos dados. É necessário um rigor metodológico capaz de transformar registros administrativos em evidências analíticas confiáveis para apoiar a tomada de decisão. Foi para enfrentar esse desafio que a Plataforma Prisma foi desenvolvida.

Data Methodology Health Policy Health Strategy Oncology Public Policy

Conectando dados complexos da oncologia a decisões mais inteligentes por meio de informações claras e acessíveis.

Atlas dos Centros de Cuidado do Câncer

Cliente: Oncoguia Compreender a assistência oncológica exige muito mais do que conhecimento clínico. É necessário enxergar como os pacientes são diagnosticados, tratados e acompanhados ao longo de toda a rede de atenção à saúde. O Atlas da Oncoguia foi desenvolvido para tornar essa realidade mais transparente, oferecendo uma visão estruturada da infraestrutura e da capacidade assistencial da oncologia brasileira.

Health Policy Health Systems Oncology Public Health Analytics

Revelando a dinâmica da assistência oncológica no sistema de saúde brasileiro.

Radar do Câncer

Cliente: Oncoguia O sistema público de saúde brasileiro produz um volume extraordinário de dados. No entanto, grande parte dessas informações permanece fragmentada em diferentes bases administrativas, dificultando a transformação de registros brutos em evidências capazes de revelar como a assistência é efetivamente prestada. O Radar do Câncer foi desenvolvido para superar esse desafio.

Data Products Health Systems Healthcare Analytics Oncology Public Health Data

Thought Leadership

Publications & Speaking

A body of work focused on the intersection of healthcare systems, evidence, and strategic decision-making. Through publications, lectures, and executive discussions, these contributions explore how data, policy, and market dynamics shape access, innovation, and long-term value in healthcare.

Speaking2025

Real-World Evidence in Clinical Research: Concepts, Applications, and Strategic Impact

SBMF - Associação Brasileira de Medicina Farmacêutica - Evento "Dilemas da Pesquisa Clínica"

A talk on the role of real-world data and real-world evidence in expanding the understanding of treatment effectiveness and safety beyond controlled clinical trials. The presentation explored how RWD is reshaping clinical research and supporting better regulatory and healthcare decision-making.

Speaking2024

Data-Driven Decision-Making in Healthcare

IEEPO Roche

A presentation at Roche’s IEEPO (International Experience Exchange with Patient Organisations) on how data can strengthen healthcare decision-making. The talk explored how patient organizations and health leaders can leverage evidence and analytics to drive more informed and impactful decisions.

Publication2023

Prevented cases of neural tube defects and cost savings after folic acid fortification of flour in Brazil

PLoS One

An economic analysis of neural tube defects in Brazil, evaluating the healthcare costs associated with these conditions and the impact of mandatory folic acid fortification. The study highlights how population-level prevention strategies can reduce disease burden and generate substantial savings for the health system.
Speaking2023

Healthcare Financing: Cost or Investment?

10º Congresso Todos Juntos Contra o Câncer (TJCC)

A presentation at the Todos Juntos Contra o Câncer (TJCC) forum exploring the strategic perspective of healthcare financing in oncology. The talk examined whether health expenditures should be viewed as costs or as long-term investments in population health and system sustainability.

Poster2023

Patients’ epidemiology in stage III, unresectable non-small-cell lung carcinoma: A real-world analysis in Brazil.

Journal of Clinical Oncology - ASCO Annual Meeting

A real-world analysis of lung cancer treatment patterns in Brazil’s public health system, estimating the population of stage III unresectable NSCLC patients eligible for consolidation therapy after chemoradiation. The study provides strategic evidence to support planning, budget impact assessments, and policy decisions for the adoption of new oncology therapies in SUS.
Publication2022

Como uma ferramenta de prescrição eletrônica possibilita uma melhor qualidade na prescrição para os pacientes [PT-BR]

JBES - Jornal Brasileiro de Economia da Saúde

Análise de erros de medicação e interações medicamentosas com base em dados de prescrição eletrônica no Brasil. O estudo demonstra como a análise estruturada de dados pode identificar riscos evitáveis e apoiar decisões que aumentam a segurança do paciente e a qualidade da assistência farmacoterapêutica.
Publication2022

Return to work after breast cancer: Disparities among patients treated in public and private hospitals in Brazil

San Antonio Breast Cancer Symposium

An analysis of return-to-work outcomes among Brazilian breast cancer survivors, examining how clinical, psychological, and workplace factors influence recovery and professional reintegration. The study highlights structural and organizational elements that shape patients’ ability to resume work after treatment.
Publication2021

Características demográficas e utilização de recursos por pacientes com dermatite atópica no Sistema Único de Saúde (SUS) [PT-BR]

JBES - Jornal Brasileiro de Economia da Saúde

Estudo de Real-World Evidence sobre dermatite atópica no SUS, analisando o perfil dos pacientes e a utilização dos recursos em saúde. A pesquisa gera evidências sobre o impacto da doença no sistema público, apoiando decisões relacionadas a protocolos clínicos, planejamento assistencial e estratégias terapêuticas.
Speaking2019

Big Data and Artificial Intelligence in Oncology: From Data to Predictive Decision-Making

VII International Lung Cancer Symposium

An opening keynote at the VII International Lung Cancer Symposium on the role of big data and artificial intelligence in healthcare. The talk explored how advanced analytics can improve interpretation, prediction, and decision-making in oncology.

Publication2019

How is advanced melanoma treated in the Public Health System in Brazil: a call for change.

Brasilian Journal of Oncology

A real-world analysis of advanced melanoma treatment in Brazil’s public health system, highlighting a significant gap between therapeutic innovation and the treatments patients actually receive.

Philosophy

On Approach & Mindset

Read Full Philosophy

I believe the most valuable work happens where rigorous evidence meets sound strategic judgment. Data can illuminate patterns and clarify trade-offs - but it is leadership and insight that ultimately determine direction.

In healthcare and the pharmaceutical industry, challenges rarely exist in isolation. Scientific evidence, regulatory environments, market access dynamics, and institutional incentives interact in ways that shape outcomes. My work focuses on helping leaders see these dynamics more clearly - so decisions are grounded not only in information, but in a coherent understanding of the system in which they operate.

Meaningful transformation requires more than technical capability. It requires the ability to translate complex realities into clear strategic choices, align stakeholders around a shared direction, and design solutions that create lasting value rather than temporary improvements.

Clarity Over Complexity

True understanding reveals what actually matters — and removes what does not.

Evidence Over Intuition

Strategy must be grounded in evidence, not intuition alone.

Impact Over Activity

The ultimate measure of strategic work is whether outcomes improve.

Insights

Recent Thinking

View All Insights

Contact

Strategic Conversations

For leaders and organizations seeking perspective on complex challenges within healthcare and the pharmaceutical ecosystem.

This channel is intended for substantive discussions on strategic direction, market dynamics, evidence generation, and high-impact decisions where independent advisory can provide clarity.

What to Expect

  • Response within 48-72 hours for qualified inquiries
  • Initial conversation to understand the context, decision environment, and strategic objectives.
  • Assessment of fit and, when appropriate, discussion of a potential advisory engagement.
Type of Inquiry